Article Information
History
- March 13, 2021.
Article Versions
- Version 1 (March 12, 2021 - 05:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Simon Haile1,
- Aidan M. Nikiforuk2,
- Pawan K. Pandoh1,
- David D. W. Twa3,
- Duane E. Smailus1,
- Jason Nguyen4,
- Stephen Pleasance1,
- Angus Wong1,
- Yongjun Zhao1,
- Diane Eisler4,
- Michelle Moksa5,
- Qi Cao5,
- Marcus Wong5,
- Edmund Su5,
- Martin Krzywinski1,
- Jessica Nelson1,
- Andrew J. Mungall1,
- Frankie Tsang4,
- Leah M. Prentice6,
- Agatha Jassem4,7,
- Amee R. Manges2,4,
- Steven J. M. Jones1,8,
- Robin J. Coope1,
- Natalie Prystajecky4,7,
- Marco A. Marra1,8,
- Mel Krajden4,7 and
- Martin Hirst1,5,*
- 1Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada
- 2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
- 3BC Cancer Research Centre, BC Cancer, Vancouver, British Columbia, Canada
- 4British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada
- 5Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada
- 6Provincial Laboratory Medicine Services, Provincial Health Services Authority, Vancouver, British Columbia, Canada
- 7Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 8Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
- ↵*Corresponding Author:
Martin Hirst, Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, 2125 East Mall, Vancouver, BC, V6T 1Z4, Canada. Email: hirstm{at}mail.ubc.ca, Phone: 604-822-6373